2018 Global Infectious Disease Testing Market - Supplier Shares & Sales Segment Forecasts by Test & Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 27, 2018--The “2018 Global Infectious Disease Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.
The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Worldwide Market OverviewEstimated universe of laboratories performing infectious disease testing by country. Test volume and sales projections for major infectious disease diagnostic assays by country.
Opportunities and Strategic RecommendationsEmerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years. Design criteria for decentralized testing products. Alternative market penetration strategies. Potential market entry barriers and risks.
Infectious Diseases AnalyzedAIDS/HIV Adenovirus Aeromonads Bartonella Blastocystis Hominis Campylobacter Candida Chancroid Chlamydia Clostridium Coronavirus Coxsackievirus Cryptosporidium Cyclospora CMV E. Coli Echovirus Encephalitis Enterovirus EBV Giardia Gonorrhea Granuloma Inguinale Hantavirus H. Pylori Hepatitis Herpes Influenza Legionella Lyme Disease Lymphogranuloma Malaria Measles Meningitis Microsporidium Mononucleosis Mumps Mycoplasma HPV Parvovirus Pneumonia Polyomaviruses Pseudomonas Rabies RSV Rhinovirus Rotavirus Rubella Salmonella Septicemia Shigella Staphylococci Streptococci Syphilis Toxoplasmosis Trichomonas TB Vibrio West Nile Yersinia
Geographic CoverageFrance Germany Italy Japan Spain UK US
Market Segmentation AnalysisSales and market shares of major suppliers by individual test and country. Volume and sales forecasts for over 100 infectious disease assays by country, individual test and market segment: - Hospitals - Blood Banks - Commercial/Private Laboratories - Physician Offices/Group Practices - Public Health Laboratories Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). Review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Current & Emerging ProductsIn-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs. Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.
Technology ReviewAssessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing. Global listings of companies developing or marketing infectious disease diagnostic products by individual test.
Competitive AssessmentsStrategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Companies FeaturedAbbott Affymetrix Beckman Coulter/Danaher Becton Dickinson bioMerieux Bio-Rad Cepheid Diamedix DiaSorin Eiken Chemical Elitech Group Enzo Biochem Fujirebio Grifols Hologic/Gen-Probe ID Biomedical/GSK Kreat
For more information about this report visit https://www.researchandmarkets.com/research/qzqw8l/2018_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005578/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infectious Disease Testing
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/27/2018 10:09 AM/DISC: 11/27/2018 10:09 AM